The SEC alleges ADM and former executives materially inflated the reported performance of ADM’s Nutrition segment by using intersegment transactions and accounting adjustments that shifted profits from other ADM units into Nutrition (including selling goods to Nutrition at below-cost prices), and then made misleading disclosures to investors about Nutrition’s results and role in company growth.